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Abstract
Background: Pertussis, a highly contagious respiratory illness, affects people of all ages and can
have serious clinical consequences. It has been reported that from 1997–2000, 20% of all pertussis
cases required hospitalization in the US. This analysis examined demographics, case fatality rate,
resource use and costs of hospital care related to pertussis by age.
Methods: ICD-9 codes (033.0, 033.9) were used to identify cases of pertussis in hospital discharge
databases from roughly 1,000 US hospitals in 4 states (California, Florida, Maryland, Massachusetts).
Data from 1996–1999 were examined by age group. Separate analyses were done for infants (<1
year) and children (1–11 years); however, adolescent and adult cases were combined into one
group (12+ years), due to the small number of cases. Databases were used to determine
demographics, health service utilization and care costs. Cost estimates include accommodations,
ancillary and physician services, reported in 2002 US$.
Results: Of the 2,518 cases identified, 90% were infants. The inpatient case fatality rate was <1%.
Of survivors, 99% were discharged home (6% with home health care); 1% required further sub-
acute inpatient care. For the 2,266 infants, the mean LOS was 6 days at a cost of $9,586 per stay.
Children (n = 191) had a mean LOS of 3.7 and cost of $4,729; adolescents/adults (n = 61, mean age
40 years) stayed on average 3.4 days with a cost of $5,683 per hospitalization.
Conclusion: Infants are responsible for the bulk of hospitalizations and generate higher inpatient
costs. Costly hospital care occurs, however, in patients with pertussis at all ages.
Background
Bordetella pertussis is a highly contagious respiratory illness
that can have serious clinical consequences. It is endemic
in the United States (US) and every 3 – 5 years an out-
break occurs [1]. It is most commonly thought of as a
childhood disease, not ranking high on the list of differ-
ential diagnoses for adolescents or adults presenting with
respiratory symptoms. While this may be understandable
as the reported incidence of pertussis declined by 99.6%
between the mid-1930s to 1970s [2] due to effective child-
hood vaccination programs, clinicians need to be aware
that pertussis continues to be a problem that is on the rise.
Since the late 1980s, the incidence of reported pertussis
has been increasing in most age groups in the US, partic-
ularly among adolescents and adults [1,3-8]. The excep-
tion was among young children where the reported
incidence has remained stable and likely reflects protec-
tion resulting from pertussis vaccinations administered as
recommended [9]. In 2002, the greatest number of pertus-
sis cases (n = 9,771) since 1964 were reported in the US
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resulting in an incidence of 3.4 per 100,000. In the period
from 1990 to 2001, a 400% increase in the adult inci-
dence was noted [10] and this is likely an underestimation
[11]. Infants continue to be the most vulnerable group. In
2002, 21% of all reported cases were infants too young
(age < 6 months) to have started the recommended vacci-
nation program [9]. Nationwide in that year, the reported
incidence for infants less than six months old was 108.8
compared to 1.2 per 100,000 among those aged 20 years
and older [9]. According to the Centers for Disease Con-
trol (CDC), pertussis is the only disease for which child-
hood vaccination is recommended that has had an
increase in incidence in the past 20 years [10].
There is a common misconception vaccinating children
for pertussis protects them forever. That is not the case.
Immunity achieved through childhood vaccinations starts
to diminish after three years with little protection left after
twelve years [12-15]. Boosters are not recommended after
seven years of age [2] so older adolescents and adults are
vulnerable. Furthermore, those who contract pertussis
later in life may go undiagnosed, but their sustained
cough spreads the infection among family, friends, associ-
ates and health care workers [2,6,7,13,15-17].
Although outpatient management with antibiotics, usu-
ally erythromycin, is the expected treatment for pertussis
[1], hospitalization does occur for those with complica-
tions [18-21]. According to the CDC, from 1997 – 2000,
20% of all patients with reported pertussis required hos-
pitalization. This rate was much higher (63%) in infants
younger than 6 months [22]. The objective of this analysis
was to examine cases of pertussis admitted to US hospitals
over a period of four years. Case fatality rates, complica-
tions, resource use and inpatient care costs by age group
were studied.
Methods
The cost of hospital care was determined by analyzing
inpatient resource use and costs reported in all payer dis-
charge databases from four states representing different
areas of the US. Discharge and cost data from roughly
1,000 hospitals in California, Florida, Massachusetts and
Washington State for the years 1996 through 1999 were
analyzed to identify cases of pertussis, defined as those
admitted with an International Classification of Diseases
– 9th Revision – Clinical Modification (ICD-9) code of
either 033.0 or 033.9 [23] as the principal diagnosis for all
age groups. These databases contain merged discharge-
level demographic, clinical and economic data for all hos-
pital discharges reported in each state within a given year
for patients of all ages. Data on length of stay (LOS),
charges incurred, source of admission and discharge dis-
position were abstracted for each patient. Secondary diag-
nosis codes reported in the databases were examined for
complications of pneumonia in whooping cough (ICD-9
code: 484.3), other pneumonias (ICD-9 codes: 480.0–
484.1, 484.4–486), convulsions (ICD-9 codes: 780.31,
780.38), apnea (ICD-9 codes: 770.8, 786.03), encepha-
lopathy (ICD-9 codes: 348.3, 348.5) and acute respiratory
distress, failure or arrest (ICD-9 codes: 518.0, 518.81,
518.82, 786.09, 799.0, 799.1).
The acute care hospital costs reported include all accom-
modations (e.g., routine, intensive care unit, nursery),
ancillary (e.g., pharmacy, laboratory, imaging), and phy-
sician services. As costs pertaining to physicians' services
are not included in the discharge data, it was necessary to
estimate an average cost of inpatient physician services.
This estimate was derived by determining the type and fre-
quency of visit or service, applying the appropriate unit
cost for each and multiplying it by the proportion of inpa-
tients using that service. Explicit data regarding type of
visit and services are not provided; therefore, data ele-
ments from the discharge databases providing informa-
tion pertinent to physician care, such as LOS, procedure
codes, special care unit stays, emergency department use
prior to admission, admission source and discharge status
were used to establish a likely inpatient physician visit/
service profile for each age group. The appropriate Physi-
cians' Current Procedural Terminology (CPT-4) code was
assigned to each visit, service or procedure [24] in the pro-
file. A unit cost representative of diverse payers was estab-
lished using fee schedules [25,26] and published payer
ratios [27], and applied to each CPT-4 code in the profiles.
Where physician fee data from a single state were used
(i.e., Florida Medicaid physician fees), state costs were
adjusted to national values using published ratios [28].
The costs presented here are meant to reflect the economic
value of the resources consumed, regardless of who actu-
ally pays for them. They represent only direct medical
costs – those associated with the delivery of the health
care service itself. Indirect costs, such as those due to a par-
ent's lost wages when caring for a child with pertussis, are
not included. All cost estimates are reported in 2002 US
dollars. Values from previous years were inflated using
rates based on the medical care component of the US
Consumer Price Index, supplied by the Federal Bureau of
Labor Statistics for the appropriate years [29]. Hospital
charges for inpatient accommodations and ancillary serv-
ices were adjusted to costs using a cost-to-charge ratio.
There is no standard or national cost-to-charge ratio for
hospital care that is reflective of care provided to the scope
of patients included in this analysis – those of all ages and
covered by different insurers. In the absence of a standard
value, 0.61 was used based on a figure calculated by the
Commonwealth of Massachusetts Office of Health Care
Finance and Policy for hospitals in Massachusetts. The
discharge data from each state was analyzed individuallyBMC Infectious Diseases 2005, 5:57 http://www.biomedcentral.com/1471-2334/5/57
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first, then these were combined giving equal weight to
each state to avoid states with substantially larger popula-
tions from being overrepresented.
Cases were analyzed by age groups defined initially as:
infants (aged less than 1 year); children (1 through 11
years); adolescents (12 through 17 years) and adults (age
greater than 22 years); however, as the number of adoles-
cent and adult cases was insufficient to analyze as separate
groups, they were combined.
Seasonal occurrence was explored in terms of the month
of hospitalization, except for Florida that reported only
the quarter. Analyses by calendar quarter were also carried
out for all cases.
Incidence estimates for the states represented in this anal-
ysis, as well as nationwide, for the years 1996 – 1999 were
obtained from the CDC [30-33] or the individual state
Departments of Health [34-37]. When a discrepancy
occurred, the data from the source with the higher
number of cases reported for that year was used.
Results
A total of 2,518 cases admitted to hospital for pertussis
during the four-year period were identified (Table 1).
Females accounted for 51% of the admissions. The mean
age was 2.3 years (range: 0 – 83 years), but 90% of cases
were younger than 1 year (median: <1 year) and most of
the rest (8%) were for children. Admission via the emer-
gency department was noted in 45% and 3% spent time
in an observation unit prior to hospitalization.
The third quarter (July through September) accounted for
more admissions (33%) than the other quarters. For
infants and children, spring and summer months had the
most admissions, while among older patients, summer
and fall were more active (Figure 1).
The mean LOS was 6 days (median: 3.5, range: 1 – 110
days) and 13% of patients spent a portion of their stay in
an intensive care unit. The mean cost of a hospital stay was
estimated to be $9,130 per person (median: $4,600,
range: $520 – $507,697). The cumulative cost over four
years for all hospitalized pertussis cases examined in this
study was estimated to be $29.4 million. Medicaid, a
health insurance plan jointly funded by federal and state
governments for those with low income who qualify, was
the responsible payer for the majority (54%) of hospital-
ized cases. Managed care organizations were the next larg-
est payer group, responsible for almost one third (31%) of
the hospital stays.
Pneumonia was coded in 6% of cases and apnea or respi-
ratory failure in 4%. Convulsions were recorded for 1%.
Encephalopathy was recorded in less than 1% (0.3%) of
all cases. The case fatality rate was less than 1% (n = 7). Six
of the deaths occurred among infants, and the other was a
patient aged 75 years. The vast majority (99%) went home
(6% with other home health care services) and the rest
(1%) returned to long-term or residential care facilities.
During the years 1996 to 1999, the four states reported
9,605 pertussis cases, representing one third of all cases
reported in the US over that period [30-37]. Hospitalized
cases were 26% of those reported in these four states. This
proportion varied substantially by state (Figure 2).
Infants
Those less than one year of age accounted for 90% (n =
2,266) of all pertussis admissions. Males and females
were represented equally. As precise age data are not avail-
able in these data sets, the distribution by month of age
cannot be determined. A stay in an observation unit prior
to admission was noted in 3% of cases and 45% were
treated in the emergency department prior to admission.
The majority (59%) of hospitalizations for infants
occurred in the months of April through September.
Pneumonia was coded in 12% of infant cases; apnea,
Table 1: Summary of hospital stay results for pertussis by age group
Infants Children Adolescents & Adults
Pertussis cases: n (%) 2,266 (90) 191 (8) 61 (2)
Age range (years) <1 1 – 11 12 – 83
Mean age (years) * 3 40
Males (%) 50 37 46
Emergency Department (%) 45 40 45
Observation Unit Stay (%) 0 0 3
Mean Total Length of Stay (days) 6 4 3
Mean Total Cost (per stay) $9,580 $4,729 $5,310
* Age in months cannot be provided as databases used for this analysis do not provide those data.BMC Infectious Diseases 2005, 5:57 http://www.biomedcentral.com/1471-2334/5/57
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respiratory distress or failure in 16%; convulsions in less
than 1%, and encephalopathy in 0.2%. The mean LOS
was 6 days (median: 4.5, range: 1 – 110 days) and 14% of
all infants spent an average of 8 days in an intensive care
nursery or pediatric intensive care unit. The cost per hos-
pital stay averaged $9,580 (median: $4,670, range: $515
– $496,712). The inpatient case fatality rate was less than
1%. All survivors went home, of whom 6% were referred
for home health care services, with less than 1% dis-
charged on continuing intravenous drug therapy. Medic-
aid was the responsible payer for 57% of the hospital
stays.
Children
Children, aged 1 through 11 years, represented 8% (n =
191) of the admissions. The majority was female (63%)
and 40% were seen in the emergency department prior to
admission. The mean age for children was 3 years
(median: 2). The average stay was 3.7 days (median 3,
range 1 – 10 days); 15% had pneumonia coded; 5% con-
vulsions and 8% apnea, respiratory distress or failure.
Admissions for children were more in the summer
months, (58%) in the months of June through Septem-
ber. The cost per hospital stay, estimated at $4,729
(median: $4,400, range: $537 – $49,945), was the lowest
of the three age groups. This was not merely a reflection of
the shorter stays but also a lower average per diem cost
($1,233) compared to infants ($1,347) and adolescents/
adults ($1,612). No children died during hospitalization;
all were discharged home (4% with home health care
services). Medicaid (42%) and managed care
Admissions for pertussis by age group for years 1996 – 1999 by months of hospitalization Figure 1
Admissions for pertussis by age group for years 1996 – 1999 by months of hospitalization.
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organizations (39%) were responsible for most of the
hospital stays.
Adolescents and adults
Those aged 12 and older represented only 2% (n = 61) of
the hospitalized cases. Slightly more than half (54%) of
them were female; mean age 40 years (median: 40, range:
12 – 83 years, Figure 3). Adults (mean age 50 years,
median 49 years, range: 22 – 83) had the highest rate
(48%) of admissions via the emergency department while
the 17 adolescents (mean age: 13.5 years, range: 12–18
years) had the lowest rate (29%) of all groups, but 17%
spent time in an observation unit prior to hospitalization.
One third (32%) of these admissions occurred between
July and September; another 28% were admitted from
October through December. The mean LOS was 3.4 days
(median: 3, range: 1–11 days) and did not vary apprecia-
bly by age (adolescents, mean: 3, median: 3.2 days; adults,
mean 3.4, median 3 days). In the small sample of adoles-
cents, no one spent time in an intensive care unit, whereas
11% of the adults did, an average of one day. Pneumonia
was noted in 11%; respiratory distress or failure in 8%;
and convulsions in 2%. Among these patients, only one,
aged 75 years died during hospitalization. The average
cost per stay was $5,310 (median: $4,293, range: $685 –
$27,625). All survivors went home, with 4% referred for
Number and proportion of hospitalized compared to all reported pertussis cases by state for 1996 – 1999 Figure 2
Number and proportion of hospitalized compared to all reported pertussis cases by state for 1996 – 1999.
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home health care. Managed care organizations were the
responsible payer for 43% of the patients in this group,
the largest primary payer for both adolescents and adults.
In the adult group, Medicare was the primary payer for
18% of the cases. Medicare is the federally funded health
insurance program for those aged 65 years and older, as
well as some younger patients who qualify because of
disabilities.
Discussion
This study shows that hospitalization is a common conse-
quence of pertussis severe enough to be diagnosed and
reported – one quarter of the cases of pertussis in these
four states were admitted. Almost all of these patients
admitted with pertussis survived and returned home, yet
these results show that the economic consequences of per-
tussis at any age can be considerable. This has budgetary
implications for both the public and private sector, as the
responsible payers for the majority of cases were Medicaid
or managed care organizations. Caring for patients with
pertussis who require hospitalization generates millions
of dollars in health care expenses and yet this substantial
amount is a conservative estimate as it reflects but one
aspect of care. As the focus of this analysis was limited to
examining direct medical care costs incurred during hos-
pitalization, post-acute care and outpatient care costs were
Age distribution of adolescent/adult hospitalized pertussis cases Figure 3
Age distribution of adolescent/adult hospitalized pertussis cases.
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not included in the estimates. Most patients will be
treated as outpatients and will use other health care
services, such as office and emergency department visits,
and antibiotics. Neither those costs nor indirect costs have
been considered in this analysis; however, a study exam-
ining pertussis cases in one New York county over a six
year period from 1989–1994 [38] reporting inpatient and
outpatient care costs noted that the cost of hospitalization
represented one of the two largest contributing costs asso-
ciated with pertussis. Furthermore, this study and another
[39] by the same author, also examined indirect costs
related to pertussis and found that work-related (e.g., lost
work days, decrease in productivity) costs were responsi-
ble for more than 60% of the overall cost of pertussis
when both direct and indirect costs were considered.
Thus, while the cost of hospital care provides a key com-
ponent of pertussis-related care costs and must be consid-
ered in any economic analysis of the disease, it does not
convey fully the economic impact of the disease.
The sample size for adolescents and adults in this analysis
was small. There are several possible reasons for this. Per-
tussis in older patients often presents in an atypical man-
ner without the characteristic whoop [2,6,7,13], which
may contribute to misdiagnosis. In such circumstances,
those cases would not be identified by the pertussis-
related ICD-9 codes and therefore not captured, or
counted, for this analysis. It is more likely, however, that
the severity of pertussis in older age groups does not war-
rant inpatient management as often as required for infants
and young children. In the 1993 pertussis outbreak in
Cincinnati [5], 84% of the hospitalizations were among
those less than 12 months old.
Pneumonia was noted as a complication in 6% for all
cases and in 12% of infants in our analysis. For seizures,
we report a 1% rate for all cases and <1% for infants; 0.3%
and 0.2% rates of encephalopathy in all cases and among
infants, respectively. These rates appear comparable to
those reported by the CDC based on data from 1997–
2000 [40]. Among all reported cases, pneumonia
occurred in 5.2% of pertussis cases and in 11.8% of
infants < 6 months. Seizures were reported by the CDC in
0.8% for all reported pertussis cases and 1.4% for infants;
encephalopathy among 0.1% for all cases and 0.2%
among infants. Rate reporting for other age groups is not
done in a comparable manner as the range of ages within
the child and adolescent/adult group differ; however, it
does appear that the rates of 15% among children and
11% among adolescents/adults for pneumonia coded in
our analysis are higher than rates reported for all ages over
age one year by the CDC. The reason for this discrepancy
is unknown. It may reflect an error in coding or that this
analysis is based only on more severe hospitalized cases;
whereas, the CDC is reporting complications rates for all
reported cases of pertussis.
Using data from any large administrative database raises
concern about potential coding errors. The coding error
rate for pertussis in the state databases is unknown, but it
is not uncommon for an infectious disease to be identified
with less specific codes. This has been reported for other
conditions, such as pneumonia [41]. Therefore, it is pos-
sible that pertussis cases could have been coded to more
generic respiratory conditions, such as unspecified upper
respiratory infection (ICD-9 code 465.9). In 1999, there
were 5,449 hospitalizations in these databases coded with
this non-specific principal diagnosis. It has been reported
that 39% of university students [6] who were ultimately
determined to have pertussis were first diagnosed by their
primary care provider as having an upper respiratory tract
infection. Another 48% in that study were misdiagnosed
with bronchitis.
A large proportion of the reported cases in some of the
states were hospitalized, possibly suggesting that only the
most severe cases are being reported; however, this analy-
sis showed a large disparity in these proportions among
the four states. The reason for the disparity is not known
and can not be determined based on the data available. It
is more likely, however, that there are multiple factors
contributing the variability seen in the rates of
hospitalization among states rather than a differing clini-
cal profile or admitting threshold. Among these factors
could be how pertussis cases are reported in each state, the
number of cases of infant versus adolescent/adult disease
for a state, or that many are not being diagnosed correctly
and therefore go unreported.
Based on the results of our analysis and those of others
[2,8,11,12,14,15,21], it is evident that pertussis is neither
a disease limited to childhood nor one that has been con-
quered through current immunization programs. The rise
in pertussis incidence in the past several years highlights
the growing vulnerability of those beyond the protection
afforded by childhood immunization. While newer acel-
lular pertussis vaccines may permit extension of immu-
nity to an older population, until very recently booster
doses of pertussis-containing vaccines were not available
for those over the age of seven years [1].
While efforts have been made to make the clinical com-
munity more aware of the increasing occurrence of this
disease in older patients, it has been shown that pertussis
often goes unrecognized, undiagnosed and underreported
in adolescents and adults [7,8,11,19]. Thus, the burden of
illness reflected in the results from this study, particularly
with regard to older patients may be much lower than in
reality.BMC Infectious Diseases 2005, 5:57 http://www.biomedcentral.com/1471-2334/5/57
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Clearly, the impact of immunization on the disease bur-
den and costs will depend largely on the extent of herd
immunity attained and this is not yet securely known for
any particular level of coverage.
Conclusion
The results reported in this analysis, albeit limited to one
level of management, illustrate how costly it can be to
manage pertussis when hospitalization is required. These
results provide decision makers concerned with the eco-
nomic aspects of preventing and treating pertussis with
recent and relevant cost estimates for a substantial cost
component of managing pertussis; however, to assess the
cost of an expanded vaccination program, all aspects of
the economic burden of caring for patients with pertussis,
including indirect costs, will need to be considered.
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